New Delhi | Zydus Cadila on Friday announced that it has received Emergency Use Authorisation from the Drug Controller General of India for ZyCoV-D – the world’s first plasmid DNA vaccine for Covid-19. ZyCoV-D is a three-dose vaccine which will be administered first on day zero, the 28th and then on the 56th day. With this […]
Tag: DCGI
DCGI approves DRDO’s anti-COVID drug for emergency use
New Delhi | The Drugs Controller General of India has approved an anti-COVID-19 drug developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS) for emergency use, the Defence Ministry has said. An anti-Covid-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by INMAS, a lab of the Defence Research and Development Organisation […]
Cipla gets DCGI nod to sell Covid-19 drug Favipiravir under brand ‘Ciplenza’, to be launched in first week of August
Mumbai: Drug maker Cipla Ltd. on Friday said it has received regulatory approval from Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand name Ciplenza to treat mild to moderate Covid-19 patients. Favipiravir is an off patent, oral antiviral drug that has been shown to hasten clinical […]